Jpmorgan Chase & CO Evolus, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EOLS
# of Institutions
166Shares Held
49.4MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$94.9 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$79.9 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$66.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$49.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$48 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $925M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...